FIELD: medicine, pharma.
SUBSTANCE: invention represents a method for inflammation imaging involving intravenous administration of gallium isotope applicable for radionuclide diagnostics and specified in 68Ga and 67Ga in the form of a citrate complex, and a substance blocking a metal-binding ability of blood transferrin, representing a physiologically acceptable ferric compound specified in ferric citrate, ferric tartrate, ferric lactate, ferric malate and ferric ascorbate, and imaging of areas of inflammation by positron-emission tomography and single-photon emission computed tomography.
EFFECT: inflammation imaging of enhanced information value within a short period of time following the introduction of gallium isotopes.
6 cl, 7 ex, 1 tbl, 18 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| USING RADIOPHARMACEUTICAL COMPOSITION USING LABELLED AUTOLOGOUS LEUKOCYTES TO VISUALIZE LOCAL RADIATION LESIONS BY SINGLE-PHOTON EMISSION TOMOGRAPHY | 2018 |
|
RU2708088C2 |
| LYOPHILIZATE FOR PREPARING RADIOPHARMACEUTICAL AGENT | 2017 |
|
RU2702238C2 |
| OCTAPEPTIDE FOR PRODUCING RADIOTRACERS, RADIOTRACER BASED THEREON METHOD OF DIAGNOSING TUMOURS, EXPRESSING SOMATOSTATIN RECEPTORS | 2011 |
|
RU2457215C1 |
| METHOD FOR RADIONUCLIDE DIAGNOSTICS OF MALIGNANT LYMPHOMAS | 2018 |
|
RU2706602C1 |
| OSTEOTROPIC RADIOPHARMACEUTICALS FOR PET IMAGING | 2014 |
|
RU2614235C2 |
| CONJUGATED BISPHOSPHONATES FOR DIAGNOSING AND TREATING BONE DISEASES | 2015 |
|
RU2742660C2 |
| PARAMINOHYPURIC ACID (PAH) AS A KIDNEY PROTECTOR | 2020 |
|
RU2804349C2 |
| GRPR ANTAGONISTS FOR DETECTING, DIAGNOSING AND TREATING GRPR-POSITIVE ONCOLOGICAL DISEASE | 2013 |
|
RU2821944C2 |
| RADIOPHARMACEUTICAL AGENT FOR DIAGNOSING OR TREATING (THERAPY) SKELETAL BONE INJURIES AND METHOD OF PREPARING SAID AGENT | 2008 |
|
RU2407746C2 |
| GRPR ANTAGONISTS FOR DETECTING, DIAGNOSING AND TREATING GRPR-POSITIVE ONCOLOGICAL DISEASE | 2013 |
|
RU2693465C2 |
